ArticleMolecular medicine reports2021

Humanized anti‑TLR4 monoclonal antibody ameliorates lipopolysaccharide‑related acute kidney injury by inhibiting TLR4/NF‑κB signaling.

Qiuhua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.